Publicaciones científicas
When Cancer Vaccines Go Viral
15-ago-2019
| Revista: Clinical Cancer Research
David Repáraz, Diana Llopiz, Pablo Sarobe
Abstract
Induction of antitumor responses by vaccines requires strong immunogens. Heterologous viral prime/boost immunization with the BN-CV301 vaccine promotes activation of immune responses that provide a clinical benefit to patients with cancer. This viral platform may be used to harbor different antigens and prime tumor immunity potentially useful for combinatorial strategies.
CITA DEL ARTÍCULO Clin Cancer Res. 2019 Aug 15;25(16):4871-4873. https://doi.org/10.1158/1078-0432.ccr-19-1652https://doi.org/10.1158/1078-0432.ccr-19-1652. Epub 2019 Jun 21.
Nuestros autores
David Repáraz Pernaut
Dra.
Diana Llópiz Khatchikian
Investigadora Asociada
Programa de Investigación de Inmunología e Inmunoterapia
Investigador | Investigador principal
Grupo de Investigación en Desarrollo de Vacunas